US2005187213A1PendingUtilityA1

Meloxicam for the treatment of respiratory diseases in pigs

50
Assignee: BOEHRINGER INGELHEIM VETMEDPriority: Feb 23, 2004Filed: Feb 1, 2005Published: Aug 25, 2005
Est. expiryFeb 23, 2024(expired)· nominal 20-yr term from priority
Inventors:Ingo LangIoannis Papatsas
A61P 31/14A61P 31/00A61P 31/12A61P 31/10A61P 11/00A61K 31/5415A61K 45/06A61K 31/65
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of treating or preventing a respiratory disease in a pig, the method comprising administering to the pig in need thereof an effective amount of meloxicam or a pharmaceutically acceptable salt thereof.

Claims

exact text as granted — not AI-modified
1 . A method of treating or preventing a respiratory disease in a pig, the method comprising administering to the pig in need thereof an effective amount of meloxicam or a pharmaceutically acceptable salt thereof.  
     
     
         2 . The method according to  claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered systemically or orally.  
     
     
         3 . The method according to  claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered in a daily dose ranging from 0.01 mg/kg to 5.0 mg/kg.  
     
     
         4 . The method according to  claim 2 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered in a daily dose ranging from 0.01 mg/kg to 5.0 mg/kg.  
     
     
         5 . The method according to  claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered by injection.  
     
     
         6 . The method according to  claim 2 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered by injection.  
     
     
         7 . The method according to  claim 1 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered via drinking water or as top dressing on feed in soluble granules.  
     
     
         8 . The method according to  claim 2 , wherein the meloxicam or a pharmaceutically acceptable salt thereof is administered via drinking water or as top dressing on feed in soluble granules.  
     
     
         9 . The method according to  claim 1 , wherein an antibiotic is administered in conjunction with the meloxicam or a pharmaceutically acceptable salt thereof.  
     
     
         10 . The method according to  claim 2 , wherein an antibiotic is administered in conjunction with the meloxicam or a pharmaceutically acceptable salt thereof.  
     
     
         11 . The method according to  claim 9 , wherein the antibiotic is selected from the group consisting of β-lactams, quinolones, tetracyclines, sulfonamides, fenicoles, and macrolides.  
     
     
         12 . The method according to  claim 10 , wherein the antibiotic is selected from the group consisting of β-lactams, quinolones, tetracyclines, sulfonamides, fenicoles, and macrolides.  
     
     
         13 . The method according to  claim 9 , wherein the antibiotic is oxytetracycline or chlorotetracycline.  
     
     
         14 . The method according to  claim 10 , wherein the antibiotic is oxytetracycline or chlorotetracycline.  
     
     
         15 . The method according to  claim 1 , wherein the disease is Porcine Respiratory Disease Complex and the pig is a growing or fattening pig.  
     
     
         16 . The method according to  claim 2 , wherein the disease is Porcine Respiratory Disease Complex and the pig is a growing or fattening pig.  
     
     
         17 . The method according to  claim 1 , wherein the disease is caused by mycoplasmas, bacteria, or viruses.  
     
     
         18 . The method according to  claim 2 , wherein the disease is caused by mycoplasmas, bacteria, or viruses.  
     
     
         19 . The method according to  claim 1 , wherein the disease is caused by  Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, Arcanobacterium pyogenes,  Swine Influenza Virus, Aujetzky's Virus, Porcine Reproductive and Respiratory Syndrome Virus, Porcine Circovirus, and Transmissible Gastroenteritis and Porcine Respiratory Coronavirus.  
     
     
         20 . The method according to  claim 2 , wherein the disease is caused by  Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Pasteurella multocida, Arcanobacterium pyogenes,  Swine Influenza Virus, Aujetzky's Virus, Porcine Reproductive and Respiratory Syndrome Virus, Porcine Circovirus, and Transmissible Gastroenteritis and Porcine Respiratory Coronavirus.  
     
     
         21 . The method according to  claim 1 , wherein the disease is caused by  Actinobacillus  spp.,  Streptococcus  spp., or  Staphylococcus  spp.  
     
     
         22 . The method according to  claim 2 , wherein the disease is caused by  Actinobacillus  spp.,  Streptococcus  spp., or  Staphylococcus  spp.  
     
     
         23 . A ready-to-use two-component pharmaceutical composition for the treatment of respiratory diseases in pigs, the composition comprising: 
 (a) a first component comprising meloxicam or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier; and    (b) a second component comprising one or more antibiotics selected from the group consisting of β-lactams, quinolones, tetracyclines, sulfonamides, fenicoles, and macrolides, and a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2005187213A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.